These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7807500)

  • 1. Abnormalities of rheology and coagulation in hypertension.
    Lip GY; Beevers DG
    J Hum Hypertens; 1994 Sep; 8(9):693-702. PubMed ID: 7807500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood viscosity and thrombosis: clinical considerations.
    Smith BD; La Celle PL
    Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.
    Lip GY; Blann AD; Jones AF; Lip PL; Beevers DG
    Am J Cardiol; 1997 Dec; 80(12):1566-71. PubMed ID: 9416937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood rheology in arterial hypertension.
    Zannad F; Stoltz JF
    J Hypertens Suppl; 1992 Jul; 10(5):S69-78. PubMed ID: 1403236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
    Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
    J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of stress electrocardiogram on platelet function, concentration of von Willebrand factor and fibrinogen in hypertensive patients and healthy subjects].
    Torres-Guerra E; Diez-Ewald M; Vizcaíno G; Arteaga-Vizcaíno M; Sulbarán T
    Invest Clin; 2000 Jun; 41(2):105-16. PubMed ID: 10961046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The investigation of a heart valve patient with suspected hypercoagulability.
    Gough SC; Prentice CR
    J Heart Valve Dis; 1993 Jan; 2(1):7-17. PubMed ID: 8269113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
    Lee KW; Blann AD; Lip GY
    Am J Hypertens; 2005 Jan; 18(1):104-15. PubMed ID: 15691624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
    J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal haemorheology, endothelial function and thrombogenesis in relation to hypertension in acute (ictus < 12 h) stroke patients: the West Birmingham Stroke Project.
    Lip GY; Blann AD; Farooqi IS; Zarifis J; Sagar G; Beevers DG
    Blood Coagul Fibrinolysis; 2001 Jun; 12(4):307-15. PubMed ID: 11460015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical implications of rheology in cardiovascular diseases].
    Raddino R; Ferrari R; Scarabelli TM; Portera C; Galeazzi G; Sarasso L; Ascari E; Visioli O
    Recenti Prog Med; 2002 Mar; 93(3):186-99. PubMed ID: 11942172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of the von Willebrand factor with platelets and thrombosis.
    Perutelli P; Mori PG
    Recenti Prog Med; 1997 Nov; 88(11):526-9. PubMed ID: 9401429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of von Willebrand factor in platelet thrombus formation.
    Ruggeri ZM
    Ann Med; 2000 Dec; 32 Suppl 1():2-9. PubMed ID: 11209976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of rheological and haemostatic factors in hypertension.
    Lee AJ
    J Hum Hypertens; 1997 Dec; 11(12):767-76. PubMed ID: 9468002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities in thrombogenic and rheologic factors in Nigerian hypertensive patients.
    Ogunlade OA; Fasanmade AA
    Afr J Med Med Sci; 2001 Dec; 30(4):291-4. PubMed ID: 14510106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
    Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
    Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.